Galvanize Therapeutics® Inc

Surgical Instruments & Devices
$144.7Mtotal raised · 5 rounds on record
8open roles
$165kmedian advertised pay
$96.1Mlatest round · Venture round · Jul 2025 · 16 mo ago

Overview

Galvanize Therapeutics designs pulsed electric field energy devices for the surgical ablation of soft tissue, engineered to work with the body's biology.

Key facts

As of Nov 13, 2026, Alion lists 8 open roles at Galvanize Therapeutics® Inc. Galvanize Therapeutics® Inc is headquartered in Redwood City, United States. It was founded in 2020. It has raised $144.7M in 3 funding rounds. The latest round is Venture - Series Unknown of $96.1M, announced in 2025. The median pay stated in its open roles is $165k, across 7 postings that state pay.

Open roles
8Its careers board, read on Nov 13, 2026
Headquarters
Redwood City, United StatesAlion company profile, updated Nov 13, 2026
Founded
2020Alion company profile, updated Nov 13, 2026
Total raised
$144.7MSum of 3 equity rounds Alion knows
Latest round
Venture - Series Unknown · $96.1M · Jul 7, 2025SEC Form D filing · sec.gov
Median advertised pay
$165kPay stated in 7 open postings
Technologies in its job postings
22Named in its job postings

Funding and backers

Total raised
$144.7M
5 rounds on record
Latest round
$96.1M
Venture round · Jul 2025 · 16 mo ago
Hiring now
8
+5 posted in 30 days
Backers
3
Xontogeny, Apple Tree Partners
The money's age
Due for its next round
16 months since the last round · and hiring
Momentum
40/100
hiring for its size, in the news
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 11, 2025 Board appointment David Lewis, Director · SEC Form D Jul 7, 2025 Raised a round Venture round $96.1M · SEC Form D Mar 9, 2022 Took on debt financing $4M · SEC Form D Feb 23, 2022 Took on debt financing $2M · SEC Form D Mar 20, 2020 Raised a round Venture round $6.1M · SEC Form D 2020 Founded Oct 8, 2015 Raised a round Venture round $42.5M · SEC Form D
Tractionpublic signals, read monthly
Web presence
top 8%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jul 2025 $96.1M — SEC Form D
Debt Financing Mar 2022 $4M — SEC Form D
Debt Financing Feb 2022 $2M — SEC Form D
Venture round Mar 2020 $6.1M — SEC Form D
Venture round Oct 2015 $42.5M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Galvanize Therapeutics, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Jonathan WaldstreicherExecutive OfficerSEC Form D
Doug GodshallExecutive Officer, DirectorSEC Form D
Steve AnheierExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Xontogeny accelerator Apple Tree Partners fund Sofinnova Partners fund
Investors in similar startupsfunds that back the companies most like this one
Plug and Play
backs Neurosoft Bioelectronics, ORtelligence
TransLink Capital
backs 2026 Point Robotics MedTech Inc.
Supernova Invest
backs Keranova
Mérieux Equity Partners
backs Keranova
BeAngels
backs Lys Medical
Park City Angels
backs OmniGuide
Similar startupsby what they do, their industry and backers
OmniGuide
OmniGuide advanced surgical technology is engineered to deliver an optimized surgical experience and superior patient outcomes.
2026 Point Robotics MedTech Inc.
Join us witnessing the spinal surgery revolution.. Pioneering new possibilities in the OR. Combining clinical experiences and technologies…
Vascular Technology, Incorporated (VTI)
Surgical Doppler Systems and Doppler Probes. Suction Irrigation Products and Specialized Surgical Devices.
ORtelligenceVenture round $550k · 3 yr ago · Founded 2020 · 11-50 employees
0 About Us Founded in 2018 by industry experts and world-class surgeons, we are committed to advancing healthcare, enabling the best…
renervaVenture round $325k · 13 mo ago · Founded 2017 · 11-50 employees
Renerva is an innovative medical device company committed to developing the next generation of surgical solutions to improve healing…
Neurosoft BioelectronicsSeed $7.5M · 5 mo ago · Founded 2020 · 11-50 employees · 1 role
Discover our deeptech vision with a medtech execution, advancing Brain-Computer Interfaces (BCI) through ultra-soft, minimally invasive…

Jobs

$160k – $175k per year · In office · Full-Time · 8+ years exp · Bachelor's Degree · Redwood City
ISO 10993
Apply
$145k – $165k per year · Remote (United States) · Full-Time · 12+ years exp · Bachelor's Degree
SAS
SPSS
GCP
Chips/EDA
Minitab
Apply
$150k – $170k per year · In office · Full-Time · 7+ years exp · Redwood City
SolidWorks
SpaceTech
FMEA
MedTech
ISO 13485
ISO 14971
21 CFR Part 820
Design Controls
Verification & Validation
Apply
$115k – $130k per year · In office · Full-Time · 2+ years exp · Bachelor's Degree · Redwood City
ISO 13485
ISO 14971
21 CFR Part 820
Verification & Validation
CAPA
Apply
$105k – $120k per year · In office · Full-Time · 2+ years exp · Bachelor's Degree · Redwood City
FMEA
MedTech
ISO 13485
CAPA
Apply
All 8 jobs at Galvanize Therapeutics® Inc salaries, cities, levels and how long each has been open

Salary insights

Compensation ranges based on this company's open jobs
Median
$165k
Typical range
$95k – $195k
Open positions
7
7 Jobs
Junior 28.6%
Senior 57.1%
Staff 14.3%
Level Jobs Median Typical range
Junior 2 $125k $120k – $130k
Senior 4 $170k $95k – $195k
Staff 1 $170k $170k
Highest paying role Sr. Manager FP&A, Commercial & Operations $195k
Normalized to USD per year
All salaries at Galvanize Therapeutics® Inc By role, level and city, against the market · 7 jobs with pay

Growth

Hiring Momentum
24/100
Hiring freeze
Open positions
8
0 opened / 0 closed in 30 days
Median time-to-fill
49 days
faster than 27% of the market
ATS activity
Every ~6 hours
Today
Hiring Dynamics 0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Sales
23% ▼
Finance
15% ▼
Science & Research
15%
Industrial Engineering
15% ▲
Administrative
8% ▲
Legal
8% ▲

Financials

Total raised
$150.7M
Latest round
Venture - Series Unknown
Funding rounds
5
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $96.1M Details
Debt Financing 2022 $4M Details
Debt Financing 2022 $2M Details
Venture - Series Unknown 2020 $6.1M Details
Venture - Series Unknown 2015 $42.5M Details

People

Jonathan Waldstreicher
Executive Officer
SEC Form D
Doug Godshall
Executive Officer, Director
SEC Form D
Steve Anheier
Executive Officer
SEC Form D
Seth Harrison
Director
SEC Form D
Antoine Papiernik
Director
SEC Form D
Zack Scott
Director
SEC Form D
David Lewis
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Tech stack

Technologies named in job postings at Galvanize Therapeutics® Inc over the last 12 months, by layer, with the share of postings for each.
Technologies in use
22
Postings analysed
9
Stack modernity
57/100
Languages
SAS
SPSS
Cloud & platforms
GCP
Power BI
Sign in to see how your skills match this stack Sign In
Full Galvanize Therapeutics® Inc tech stack 22 technologies · by team · pay by technology · changes · similar stacks

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors3
XontogenyVia a fund
27 portfolio companies: Zucara, TORL BioTherapeutics LLC, VivoSense and 24 more
Apple Tree PartnersVia a fund
28 portfolio companies: Johnson & Johnson, Smith+Nephew, Eledon and 25 more
Sofinnova PartnersVia a fund
129 portfolio companies: IMIO, Alethio Therapeutics, Reyva and 126 more
Report a mistake

News

News newswise.com 3 months ago
Galvanize Therapeutics Announces the Latest Exploratory Evidence Suggesting Immune-Activating Potential of Aliya PEF Energy Newswise
Galvanize Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease, today announced two new peer-reviewed publications that add to the growing body evidence su
Read more
Report
Press release PRNewswire 3 months ago
Galvanize Therapeutics Announces the Latest Exploratory Evidence Suggesting Immune-Activating Potential of Aliya PEF Energy
/PRNewswire/ -- Galvanize Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and...
Read more
Report
Press release morningstar.com 3 months ago
Galvanize Therapeutics Announces the Latest Exploratory Evidence Suggesting Immune-Activating Potential of Aliya PEF Energy Read more
Report
News YahooFinance 3 months ago
Galvanize Therapeutics Announces First Commercial Procedures Using the New Aliya EX System
Galvanize Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease, today announced the completion of the first commercial procedures using its recently FDA-cl
Read more
Report
Press release PRNewswire 3 months ago
Galvanize Therapeutics Announces First Commercial Procedures Using the New Aliya EX System
/PRNewswire/ -- Galvanize Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and...
Read more
Report

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Redwood City
Redwood City United States
HQ
Get in touch
6 open roles 7 posted in 90 days $158k Avg Salary
hires for Industrial Engineering, Finance, Management
3200 Bridge Parkway, Redwood City, CA 94065
seen since Jun 2026 company site, job postings

How to cite this page

Alion, "Galvanize Therapeutics® Inc: key facts", as of Nov 13, 2026. https://alion.io/company/galvanizetx

These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0